Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results

The long-term persistence of hepatitis B surface antibody (anti-HBs) after hepatitis B vaccination among adults was not known clearly. This study aimed to assess the immunogenicity and persistence of antibodies 8 years after hepatitis B immunization with different vaccination schedules among adults...

Full description

Bibliographic Details
Main Authors: Wen Ren, Jingjing Ren, Zikang Wu, Lingzhi Shen, Huan Shan, Xuewei Dai, Jing Li, Ying Liu, Yan Qiu, Jun Yao, Lanjuan Li
Format: Article
Language:English
Published: Taylor & Francis Group 2020-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2019.1666612
_version_ 1827809720469028864
author Wen Ren
Jingjing Ren
Zikang Wu
Lingzhi Shen
Huan Shan
Xuewei Dai
Jing Li
Ying Liu
Yan Qiu
Jun Yao
Lanjuan Li
author_facet Wen Ren
Jingjing Ren
Zikang Wu
Lingzhi Shen
Huan Shan
Xuewei Dai
Jing Li
Ying Liu
Yan Qiu
Jun Yao
Lanjuan Li
author_sort Wen Ren
collection DOAJ
description The long-term persistence of hepatitis B surface antibody (anti-HBs) after hepatitis B vaccination among adults was not known clearly. This study aimed to assess the immunogenicity and persistence of antibodies 8 years after hepatitis B immunization with different vaccination schedules among adults who tested negative for hepatitis B surface antigen (HBsAg), anti-HBs, and hepatitis B core antibody (anti-HBc). A total of 771 participants who received the full vaccination course (three doses) and also had a blood sample taken 1 month after the first vaccination were recruited. Of these, 529 were excluded due to the missing data of anti-HBs 8 years after the first vaccination. Vaccinations were carried out at 0–1–3, 0–1–6 and 0–1–12 month vaccination schedules, and 104, 45, and 93 participants were included, respectively. The positive seroprotection rate was 85.9% 1 month after the third vaccination, and 58.3% 8 years later (χ2 = 54.52, P < .001), while the geometric mean titer (GMT) of anti-HBs was 158.49 mIU/mL [95% confidence interval (CI): 131.83–190.55)] and 15.14 mIU/mL (95% CI: 10.96–20.42) after 1 month and 8 years, respectively. Compared with the standard 0–1–6 month vaccination schedule, the positive seroprotection rate and the GMT of the 0–1–3 month vaccination schedule had no difference. The long-term immune effect of the 0–1–3 month vaccination schedule was better than that of the 0–1–12 month vaccination schedule. No correlation was found between the GMT of anti-HBs 1 month and 8 years later.
first_indexed 2024-03-11T22:43:44Z
format Article
id doaj.art-6f3cb6d2fd5a45f29378529884bebb38
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T22:43:44Z
publishDate 2020-03-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-6f3cb6d2fd5a45f29378529884bebb382023-09-22T08:45:33ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2020-03-0116368769210.1080/21645515.2019.16666121666612Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year resultsWen Ren0Jingjing Ren1Zikang Wu2Lingzhi Shen3Huan Shan4Xuewei Dai5Jing Li6Ying Liu7Yan Qiu8Jun Yao9Lanjuan Li10Zhejiang UniversityZhejiang UniversityZhejiang Provincial Center for Disease Control and preventionZhejiang Provincial Center for Disease Control and preventionZhejiang HospitalJingdezhen Center for Disease Control and preventionZhejiang HospitalZhejiang UniversityZhejiang UniversityZhejiang Provincial Center for Disease Control and preventionZhejiang UniversityThe long-term persistence of hepatitis B surface antibody (anti-HBs) after hepatitis B vaccination among adults was not known clearly. This study aimed to assess the immunogenicity and persistence of antibodies 8 years after hepatitis B immunization with different vaccination schedules among adults who tested negative for hepatitis B surface antigen (HBsAg), anti-HBs, and hepatitis B core antibody (anti-HBc). A total of 771 participants who received the full vaccination course (three doses) and also had a blood sample taken 1 month after the first vaccination were recruited. Of these, 529 were excluded due to the missing data of anti-HBs 8 years after the first vaccination. Vaccinations were carried out at 0–1–3, 0–1–6 and 0–1–12 month vaccination schedules, and 104, 45, and 93 participants were included, respectively. The positive seroprotection rate was 85.9% 1 month after the third vaccination, and 58.3% 8 years later (χ2 = 54.52, P < .001), while the geometric mean titer (GMT) of anti-HBs was 158.49 mIU/mL [95% confidence interval (CI): 131.83–190.55)] and 15.14 mIU/mL (95% CI: 10.96–20.42) after 1 month and 8 years, respectively. Compared with the standard 0–1–6 month vaccination schedule, the positive seroprotection rate and the GMT of the 0–1–3 month vaccination schedule had no difference. The long-term immune effect of the 0–1–3 month vaccination schedule was better than that of the 0–1–12 month vaccination schedule. No correlation was found between the GMT of anti-HBs 1 month and 8 years later.http://dx.doi.org/10.1080/21645515.2019.1666612hepatitis b virusvaccineimmune effectadultimmunogenicity
spellingShingle Wen Ren
Jingjing Ren
Zikang Wu
Lingzhi Shen
Huan Shan
Xuewei Dai
Jing Li
Ying Liu
Yan Qiu
Jun Yao
Lanjuan Li
Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
Human Vaccines & Immunotherapeutics
hepatitis b virus
vaccine
immune effect
adult
immunogenicity
title Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
title_full Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
title_fullStr Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
title_full_unstemmed Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
title_short Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
title_sort long term persistence of anti hbs after hepatitis b vaccination among adults 8 year results
topic hepatitis b virus
vaccine
immune effect
adult
immunogenicity
url http://dx.doi.org/10.1080/21645515.2019.1666612
work_keys_str_mv AT wenren longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT jingjingren longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT zikangwu longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT lingzhishen longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT huanshan longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT xueweidai longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT jingli longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT yingliu longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT yanqiu longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT junyao longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults
AT lanjuanli longtermpersistenceofantihbsafterhepatitisbvaccinationamongadults8yearresults